InsiderClue
← All stocks

abrdn Healthcare Opportunities Fund

THQ Net buying
CIK 0001604522 #2709 in the set updated 18 Sep 2026
Bought (120 mo)
$669.32K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$669.32K
+$669.32K against sales at will

By person

9 insiders · 15 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
OMSTEAD DANIEL R
President
$516.28K (5)
—
+$516.28K
31,202
$576.92K
+3,020%
Kent Thomas M
Director
$25.90K (1)
—
+$25.90K
1,400
$25.89K
—
REARDON WILLIAM S
Director
$24.94K (1)
—
+$24.94K
1,196
$22.11K
—
Goetz Kathleen
Director
$23.63K (3)
—
+$23.63K
1,696
$31.37K
+209.5%
DiMartino Rose
Director
$21.30K (1)
—
+$21.30K
1,000
$18.49K
—
Reit Todd
Director
$18.44K (1)
—
+$18.44K
1,000
$18.49K
—
Maher Bill
Director
$18.25K (1)
—
+$18.25K
1,000
$18.49K
—
Mahai Chris LaVictoire
Director
$10.50K (1)
—
+$10.50K
568
$10.50K
—
Bailey Jeffrey Allen
Director
$10.08K (1)
—
+$10.08K
570
$10.54K
—

No percentages here. abrdn Healthcare Opportunities Fund reports its share count only per share class, which the XBRL frames API does not carry.

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Mahai Chris LaVictoire
16 Jul 2026
Director
Buy
568
$18.49
$10.50K
DiMartino Rose
16 Jul 2024
Director
Buy
1,000
$21.30
$21.30K
Goetz Kathleen
9 Apr 2024
Director
Buy
600
$19.54
$11.72K
Reit Todd
2 Jan 2024
Director
Buy
1,000
$18.44
$18.44K
Maher Bill
28 Dec 2023
Director
Buy
1,000
$18.25
$18.25K
Goetz Kathleen
23 Mar 2022
Director
Buy
69
$21.69
$1.50K
Goetz Kathleen
26 Jan 2022
Director
Buy
479
$21.73
$10.41K
REARDON WILLIAM S
25 Feb 2021
Director
Buy
1,196
$20.85
$24.94K
Bailey Jeffrey Allen
23 Sep 2020
Director
Buy
570
$17.68
$10.08K
OMSTEAD DANIEL R
17 Mar 2020
President
Buy
7,300
$14.67
$107.10K
OMSTEAD DANIEL R
25 Oct 2018
President
Buy
6,000
$17.43
$104.58K
OMSTEAD DANIEL R
17 Oct 2018
President
Buy
5,902
$18.19
$107.37K
OMSTEAD DANIEL R
11 Oct 2018
President
Buy
5,500
$17.59
$96.76K
OMSTEAD DANIEL R
10 Oct 2018
President
Buy
5,500
$18.27
$100.47K
Kent Thomas M
25 Jan 2018
Director
Buy
1,400
$18.50
$25.90K

What was left out

Form 4 filings counted 15
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 29 Jan 2018